Interventional × Congenital Abnormalities × Other neoplasm × Clear all
NCT00544115 2025-06-10

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

City of Hope Medical Center

Phase 2 Active not recruiting
260 enrolled 13 charts
NCT00424242 2021-09-08

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Northwestern University

Phase EARLY_PHASE1 Completed
15 enrolled
NCT00726830 2020-09-24

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

M.D. Anderson Cancer Center

Phase NA Terminated
1 enrolled 3 charts
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
NCT00376922 2017-05-30

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Wake Forest University Health Sciences

Phase NA Completed
65 enrolled
NCT00719563 2017-02-09

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
364 enrolled 29 charts
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
NCT00062231 2012-09-24

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Terminated
351 enrolled
NCT00666211 2012-09-06

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
98 enrolled 14 charts
NCT00006379 2011-12-08

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Case Comprehensive Cancer Center

Phase 2 Completed
58 enrolled
NCT00740467 2010-01-28

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
NCT00004058 2010-01-26

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Rutgers, The State University of New Jersey

Phase 1 Terminated